Total Live Articles: 471

Bell’s palsy

NICE CKS Bell’s palsy. Last revised Feb 2023.

Bell’s Palsy

Bell’s palsy is an idiopathic, unilateral facial nerve (cranial nerve VII) palsy with rapid onset.

This updated UKMLA guide to Bell’s palsy is based on NICE CKS, which covers causes, risk factors, symptoms, diagnosis and management.

Causes and Risk Factors

Bell’s palsy is idiopathic

  • Facial nerve palsy may be due to inflammation and oedema
  • Herpes simplex virus, herpes zoster virus, and autoimmunity may contribute to the development of Bell’s palsy, but the exact pathogenesis is controversial, and the significance of these factors remains unclear

Risk factors:

  • 15-45 y/o
  • Pregnancy (esp. 3rd trimester and first 2 weeks postpartum) – 2-4x risk
  • Diabetes
  • Immunocompromised
  • Obesity
  • Hypertension
  • Upper respiratory conditions

Clinical Features

Rapid onset (<72 hours) of unilateral facial muscle weakness / paralysis

  • Reduction or loss of movement on the affected side
  • Sagging of the eyelid / corner of the mouth
  • Drooping of the eyebrow / corner of the mouth
  • Loss of nasolabial fold
  • On examination: weakness or paralysis of ipsilateral upper and lower facial muscles, affecting facial expression such as
    • Raising the eyebrow
    • Closing the eye tightly
    • Smiling
    • Puffing out the cheeks

Other features:

  • Eye
    • Dry eyes (30%), eye pain, excessive tearing
    • Poor / incomplete eye closure
  • Ear
    • Post-auricular and ear pain (~50%)
    • Hyperacusis (<5%)
  • Mouth
    • Change in taste (~35%)
    • Difficulty chewing and dry mouth (~20%)

Relevant anatomy of the facial nerve (CN VII)

Facial nerve innervates:

  • Muscles of facial expression (forehead, eyelids, cheeks, lips and mouth)
  • Orbicularis oculi (responsible for eye closure)
  • Anterior 2/3 of the tongue via the chorda tympani branch (responsible for taste)
  • Parasympathetic supply to lacrimal and salivary glands (greater petrosal nerve)
  • Nerve to stapedius muscle (responsible for the stapedial reflex)
  • Sensory fibres to part of the external ear

In Bell’s palsy, there should be no features suggestive of an alternative neurological diagnosis.

There should be no:

  • Facial sensory loss – Bell’s palsy causes facial weakness, not loss of facial sensation (which is innervated by the CN V, not CN VII)
  • Limb weakness and sensory loss
  • Dysphasia
  • Neglect
  • Visual field defect

Differential Diagnosis

The most important differential diagnosis of Bell’s palsy is a UMN facial weakness, such as from a stroke or other intracranial lesion affecting the corticobulbar pathway

Features suggestive of LMN facial weakness (e.g. Bell’s palsy) Features suggestive of UMN facial weakness (e.g. stroke)
  • Ipsilateral face involvement
  • Involves the entire face (both upper and lower face)
  • No other signs apart from facial nerve palsy
  • Contralateral face involvement
  • Forehead sparing: involves only the lower face
  • Other neurological features possible, such as
    • Facial sensory loss
    • Limb weakness and sensory loss
    • Dysphasia
    • Neglect
    • Visual field defect
Rationale on forehead sparing in UMN facial weakness:

  • The upper facial muscles receive bilateral cortical innervation, meaning each side of the forehead receives input from both cerebral hemispheres
  • Therefore, in a unilateral UMN lesion such as a stroke, the forehead is usually spared because the unaffected hemisphere can still supply the upper face

However, in an LMN lesion (e.g. Bell’s palsy) the lesion occurs at or distal to the facial nucleus, affecting the facial nerve after cortical input has already converged. Therefore, even though the forehead receives bilateral cortical input, the final motor pathway to the ipsilateral forehead is interrupted.

Note a brainstem stroke can produce an LMN facial weakness. Therefore, forehead involvement does NOT completely exclude a stroke, esp. if there are focal neurological deficits.

Ramsay Hunt syndrome

  • Caused by reactivation of VZV in the geniculate ganglion of the facial nerve (CN VII)
  • Causes an unilateral, ipsilateral LMN facial nerve palsy, affecting both the upper and lower face (just like in Bell’s palsy)
  • Presence of additional features help distinguish it from Bell’s palsy, including:
    • Vesicular rash on the ear (esp. pinna), ear canal, or pharynx
    • Severe ear pain
    • Possible CN VIII involvement, causing sensorineural hearing loss, tinnitus and vertigo

Other differentials:

Investigation and Diagnosis

Bell’s palsy is a clinical diagnosis, after excluding alternative causes of facial weakness or paralysis

Laboratory tests and imaging are NOT necessary for clinically diagnosed Bell’s palsy

Management

Referral Criteria

Refer urgently if ANY of the following are present:

  • Facial nerve palsy may be caused by UMN cause or cancer or trauma
  • No improvement after 3 weeks of treatment
  • Incomplete recovery after 3 months of onset
  • Worsening / new neurological findings

Red flags for possible UMN cause:

  • Facial sensory loss
  • Limb weakness and sensory loss
  • Dysphasia
  • Neglect
  • Visual field defect

General Advice / Conservative Management

Advise that most patients begin to recover, even without treatment, within 2-3 weeks. Complete recovery usually occurs within 3-4 months

Advice on eye care:

  • Keep the affected eye lubricated (eye drops during the day and eye ointment at night)
  • Tape the eye closed at night if the patient is unable to close the eye
    • Eye patches are contraindicated as the eye may open under the patch, leading to corneal abrasion
  • Wear sunglasses when outdoors
  • Avoid activities that may irritate the eye (e.g. swimming and dusty environments)

Pharmacological Management

Consider oral prednisolone if the patient presents within <72 hours of onset

  • 50 mg daily for 10 days OR
  • 60 mg daily for 5 days followed by a daily reduction in dose of 10 mg (for a total treatment time of 10 days)

Antivirals alone are NOT recommended for Bell’s palsy.

Antiviral treatment in combination with a corticosteroid may be of small benefit, but seek specialist advice if this is being considered.

References

Related Articles

Stroke (Overview)

Ischaemic Stroke

Guillain-Barre Syndrome (GBS)

Sarcoidosis

Lyme Disease

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.